Pharma Earnings: Who Soared and Who Stumbled?

Big Pharma's Q2 Scorecard: Find out which drugmakers crushed expectations, which stumbled, and why Supernus Pharmaceuticals' stock skyrocketed almost 30%! We break down the earnings reports of industry giants like Bristol-Myers Squibb, Eli Lilly, and Pfizer, revealing the trends, challenges, and innovations shaping the future of branded pharmaceuticals. Hosted on Acast. See acast.com/privacy for more information.